Diphenylhydantoin and phenobarbital suppress the dopaminergic neurotoxicity of MPTP in mice
- 1 September 1986
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 128 (3) , 255-257
- https://doi.org/10.1016/0014-2999(86)90773-9
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTPEuropean Journal of Pharmacology, 1985
- Pharmacological interference with the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouseEuropean Journal of Pharmacology, 1985
- Neurochemical and Histochemical Characterization of Neurotoxic Effects of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine on Brain Catecholamine Neurones in the MouseJournal of Neurochemistry, 1985
- Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTPEuropean Journal of Pharmacology, 1984
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonismNature, 1984
- AETIOLOGY OF PARKINSON'S DISEASEThe Lancet, 1983
- Seizure susceptibility and anticonvulsant activity of carbamazepine, diphenylhydantoin and phenobarbital in rats with selective depletions of brain monoaminesNeuropharmacology, 1978
- Uptake and Binding of CatecholaminesArchives of Neurology, 1972
- Convulsive seizures and electroencephalogram changes in three patients during levodopa therapyNeurology, 1970